Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nonvasiv, officially known as Nonvasiv Technologies, Inc., is a medical technology company that focused on the development of non-invasive blood glucose monitoring systems for the management of diabetes. The company's core technology utilized proprietary electromagnetic and thermal sensors to measure glucose levels through the skin, aiming to provide a painless alternative to traditional finger-stick blood tests. Based in Darien, Connecticut, Nonvasiv sought to integrate this technology into portable devices to improve patient compliance and glycemic control. Despite obtaining several patents and developing early-stage prototypes, the company faced significant challenges in achieving the clinical precision required for FDA approval. As a result, the company never reached the commercialization stage and is currently considered inactive. Its efforts represent a significant chapter in the ongoing pursuit of non-invasive metabolic monitoring solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nonvasiv.